Prostate News Archive
22-Jan-2008
Prostate cancer worries women (Daily Telegraph)
WOMEN are initially more distressed by prostate cancer than their male partners who are diagnosed with the disease, a study has found. Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer ... (Business Wire via Yahoo! Finance)
CHICAGO----Investigators of a recent multi-institutional trial, led by principal investigator Bradley Prestidge, conclude that Cesium-131, a medical isotope used in low dose brachytherapy treatment for prostate cancer, "... has come into widespread use; and the clinical results of this trial are mature enough to be of immediate, important, practical use to practitioners." Prostate Cancer Conference at Mayo Clinic (KAAL Austin)
(KAAL) -- It's a type of cancer that some call the "couple disease". The Mayo Clinic in Rochester held a conference on prostate cancer, allowing men to gather information they and their loved ones may need in order to deal with the disease and life after. Women 'more distressed by prostate cancer' (Perth Now)
WOMEN are more distressed by prostate cancer than their male partners who are diagnosed with the disease, a study has found. GTX Shares Fall on Study Concern (AP via Yahoo! Finance)
Shares of biotechnology company GTX Inc. stumbled Monday on concerns on the risks involved with a late-stage study of the company's prostate cancer drug Acapodene.
Back to Prostate News Archive
